연구성과로 돌아가기

2023 연구자 정보 (426 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Mok, Jeongha
(Mok, J)
Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea

[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort SCIE 11.4 RESPIRATORY SYSTEM
Montgomery, R. A.
(Montgomery, RA)
Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland C-5541-2019
Montgomery, Robert

[JCR상위 11.4] A multidimensional study of the structure function ratio σLT''/σ0 from hard exclusive π± electro-production off protons in the GPD regime
[JCR상위 6.7] Observation of Correlations between Spin and Transverse Momenta in Back-to-Back Dihadron Production at CLAS12
SCIE 6.7 ASTRONOMY & ASTROPHYSICS;PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS
PHYSICS, MULTIDISCIPLINARY
stefan.diehl@exp2.physik.uni-giessen.de;
Nam, Hye-Been
(Nam, HB)
Kyungpook Natl Univ, Sch Comp Sci & Engn, 80 Daehak Ro, Daegu 41566, South Korea

[JCR상위 11.4] Use of QUIC for CoAP transport in IoT networks SCIE 11.4 COMPUTER SCIENCE, INFORMATION SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS sjkoh@knu.ac.kr;
Oh, Hyung-Joo
(Oh, HJ)
Chonnam Natl Univ, Internal Med, Sch Med, Jeonnam, South Korea
Hwasun Hosp, Jeonnam, South Korea
Chonnam Natl Univ, Med Sch, Dept Internal Med, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea
Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea
Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Gwangju 58128, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Hwasun, South Korea

0000-0002-9420-9096
Oh, Hyung-joo
[JCR상위 11.4] Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial
[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR
[JCR상위 30.5] Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial
[JCR상위 28.4] Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study
SCIE 1.5 RESPIRATORY SYSTEM
ONCOLOGY;RESPIRATORY SYSTEM
CELL BIOLOGY
ONCOLOGY
droij@jnu.ac.kr;
ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr;
jangtw22@hanmail.net;
Oh, Jee Youn
(Oh, JY)
Korea Univ, Guro Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Seoul, South Korea
Univ Guro Hosp, Div Pulm Allergy & Crit Care Med, Dept Internal Med, Seoul, South Korea
AAX-7147-2020
Oh, Jee

[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study
[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort
SCIE 11.4 RESPIRATORY SYSTEM
Park, Cheol-Kyu
(Park, CK)
제1저자 Chonnam Natl Univ, Internal Med, Sch Med, Jeonnam, South Korea
Hwasun Hosp, Jeonnam, South Korea
Chonnam Natl Univ, Med Sch, Dept Internal Med, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea
Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea
Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Gwangju 58128, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Lung & Esophageal Canc Clin,Med Sch, Hwasun, South Korea
AAT-9872-2021
Park, Cheol-Kyu
0000-0001-8701-0786
Park, Cheol Kyu
[JCR상위 11.4] Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial
[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR
[JCR상위 30.5] Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial
[JCR상위 28.4] Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer
SCIE 1.5 RESPIRATORY SYSTEM
ONCOLOGY;RESPIRATORY SYSTEM
CELL BIOLOGY
ONCOLOGY
droij@jnu.ac.kr;
ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr;
jclee@amc.seoul.kr;
Park, Hye Kyeong
(Park, HK)
Inje Univ, Dept Internal Med, Div Pulm & Crit Care Med, Ilsan Paik Hosp, Ilsan, South Korea

[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort SCIE 11.4 RESPIRATORY SYSTEM
Park, Sung Ho
(Park, SH)
교신저자 Kyungpook Natl Univ, Coll IT Engn, Sch Elect & Elect Engn, 80 Daehak Ro, Daegu 41566, South Korea
Kyungpook Natl Univ, Ctr Selforganizing Software, Daegu, South Korea
ABA-4566-2020
park, sungho
0000-0001-9356-7791
Park, Sung Ho
[JCR상위 11.4] Self-x based closed loop wearable IoT for real-time detection and resolution of sleep apnea
[JCR상위 5.2] Detecting unregistered users through semi-supervised anomaly detection with similarity datasets
SCIE 5.2 COMPUTER SCIENCE, INFORMATION SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS
COMPUTER SCIENCE, THEORY & METHODS
dudwns333@gmail.com;siminsungho@gmail.com;sjkang@ee.knu.ac.kr;
sjkang@knu.ac.kr;
Park, Yumi
(Park, Y)
Inje Univ, Coll Med, Dept Pharmacol, Busan, South Korea
Inje Univ, Coll Med, PharmacoGen Res Ctr, Busan, South Korea
Inje Univ, Ctr Personalized Precis Med TB CPMTb, Coll Med, Busan, South Korea


[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study
[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort
SCIE 11.4 RESPIRATORY SYSTEM
Seo, Hye Won
(Seo, HW)
Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea

[JCR상위 11.4] Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma
[JCR상위 11.4] Single-cell RNA sequencing reveals distinct molecular features of high-grade lung adenocarcinoma subtypes
SCIE 11.4 RESPIRATORY SYSTEM
Sharabian, Y.
(Sharabian, Y)
Thomas Jefferson Natl Accelerator Facil, Newport News, VA USA

[JCR상위 11.4] A multidimensional study of the structure function ratio σLT''/σ0 from hard exclusive π± electro-production off protons in the GPD regime SCIE 11.4 ASTRONOMY & ASTROPHYSICS;PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS stefan.diehl@exp2.physik.uni-giessen.de;
Shin, Jae-Gook
(Shin, JG)
Inje Univ, Coll Med, Dept Pharmacol, Busan, South Korea
Inje Univ, Coll Med, PharmacoGen Res Ctr, Busan, South Korea
Inje Univ, Coll Med, Ctr Personalized Precis Med TB, Busan, South Korea
Inje Univ, Busan Paik Hosp, Dept Clin Pharmacol, Busan, South Korea
Inje Univ, Ctr Personalized Precis Med TB CPMTb, Coll Med, Busan, South Korea
Inje Univ, Dept Pharmacol, Coll Med, Busan, South Korea
Inje Univ, PharmacoGen Res Ctr, Coll Med, Busan, South Korea


[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study
[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort
SCIE 11.4 RESPIRATORY SYSTEM
Shin, Kyeong-Cheol
(Shin, KC)
Yeungnam Univ, Div Pulmonol & Allergy, Dept Internal Med, Med Ctr, Daegu, South Korea

[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort SCIE 11.4 RESPIRATORY SYSTEM
Yoon, Sung Hoon
(Yoon, SH)
Pusan Natl Univ, Internal Med, Yangsan Hosp, Gyeongnam, South Korea

[JCR상위 11.4] Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial SCIE 11.4 RESPIRATORY SYSTEM
Yum, Ho-Kee
(Yum, HK)
Inje Univ, Seoul Paik Hosp, Dept Internal Med, Seoul, South Korea

[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study SCIE 11.4 RESPIRATORY SYSTEM
페이지 이동: